Application Sponsors
| ANDA 090284 | INVAGEN PHARMS |  | 
Marketing Status
Application Products
| 001 | TABLET, EXTENDED RELEASE;ORAL | 10MG | 0 | ALFUZOSIN HYDROCHLORIDE | ALFUZOSIN HYDROCHLORIDE | 
FDA Submissions
 | ORIG | 1 | AP | 2012-01-17 |   | 
| LABELING; Labeling | SUPPL | 4 | AP | 2015-01-13 | STANDARD  | 
| LABELING; Labeling | SUPPL | 5 | AP | 2015-01-13 | STANDARD  | 
Submissions Property Types
| ORIG | 1 | Null | 15 | 
| SUPPL | 4 | Null | 7 | 
| SUPPL | 5 | Null | 7 | 
TE Codes
CDER Filings
INVAGEN PHARMS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 90284
            [companyName] => INVAGEN PHARMS
            [docInserts] => ["",""]
            [products] => [{"drugName":"ALFUZOSIN HYDROCHLORIDE","activeIngredients":"ALFUZOSIN HYDROCHLORIDE","strength":"10MG","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"ALFUZOSIN HYDROCHLORIDE","submission":"ALFUZOSIN HYDROCHLORIDE","actionType":"10MG","submissionClassification":"TABLET, EXTENDED RELEASE;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )
)